指南与共识儿科与产科急症消化、代谢与肾脏急症

接受重复经颅磁刺激治疗抑郁、强迫症、精神病性和创伤相关障碍患者合并物质使用的评估与管理:德尔菲共识研究与指南

Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline.
指南 / 共识 · Am J Psychiatry · 2025-03-19
一句话结论国际24人专家组共识:rTMS患者不应因物质使用一律排除,应基于临床不稳定风险和物质使用严重度评估后决策。

数据有限,无法指导重复经颅磁刺激(rTMS)治疗抑郁、强迫症、精神病性或创伤相关障碍时如何管理合并物质使用。作者召集24名rTMS专家组成国际专家组,采用德尔菲法,经连续轮次调查并在每轮后反馈讨论,推荐条目需≥80%同意。三轮调查和反馈后多数议题达成共识,未达成共识处讨论了现有证据的局限。专家组就筛查、监测、风险评估和减轻风险,以及酒精、大麻、兴奋剂和阿片类的特定考虑给出多项共识推荐;不主张排除所有物质使用者,而应根据临床不稳定危险因素和物质使用严重度采取细致评估;物质使用最重要的安全风险是中毒或戒断状态,最多数据支持不稳定性酒精使用或非医疗兴奋剂使用时的癫痫风险;虽无证据表明合并物质使用会降低rTMS对精神障碍的疗效,但该领域数据缺乏,需谨慎。

要点

  • 物质使用最重要的安全风险是中毒或戒断状态,最多数据支持不稳定性酒精使用或非医疗兴奋剂使用时的癫痫风险。
  • 不应排除所有物质使用者,而应基于临床不稳定危险因素和物质使用严重度的评估采取细致方法。
  • 无证据表明合并物质使用会降低rTMS对精神障碍的疗效,但该领域数据缺乏,需谨慎。
  • 专家组就筛查、监测、风险评估和减轻风险及酒精、大麻、兴奋剂和阿片类的特定考虑给出共识推荐。
  • 推荐条目以≥80%同意为达成标准;未达成共识处讨论了当前证据基础的局限。

适用人群与场景

  • 接受rTMS治疗抑郁、强迫症、精神病性或创伤相关障碍的患者,合并物质使用(酒精、大麻、兴奋剂、阿片类)时

诊断标准与关键阈值

  • 推荐条目以≥80%同意为达成标准

处置流程与药物剂量

  • 不主张排除所有物质使用者,而应根据临床不稳定危险因素和物质使用严重度评估采取细致方法
  • 物质使用最重要的安全风险是中毒或戒断状态,最多数据支持不稳定性酒精使用或非医疗兴奋剂使用时的癫痫风险
  • 专家组就筛查、监测、风险评估和减轻风险,以及酒精、大麻、兴奋剂和阿片类的特定考虑给出共识推荐

红旗征与不能漏的情况

  • 中毒或戒断状态是物质使用最重要的安全风险
  • 最多数据支持不稳定性酒精使用或非医疗兴奋剂使用时的癫痫风险

研究设计与关键结果

  • 采用德尔菲法调查和专家意见,经连续轮次调查并在每轮后反馈讨论;推荐条目需≥80%同意;三轮调查和反馈后多数议题达成共识,未达成共识处讨论了现有证据局限。

证据类型、等级与局限

  • 证据类型:德尔菲共识研究与指南(专家意见)
  • 推荐条目以≥80%同意为达成标准
  • 局限:无证据表明合并物质使用会降低rTMS对精神障碍的疗效,但该领域数据缺乏,需谨慎;未达成共识处讨论了当前证据基础的局限

对床旁实践的改变

  • 接受rTMS治疗原发精神障碍的患者,不应因物质使用一律排除,应基于临床不稳定危险因素和物质使用严重度评估决策
  • 需关注中毒或戒断状态,尤其不稳定性酒精使用或非医疗兴奋剂使用时的癫痫风险
  • 对酒精、大麻、兴奋剂和阿片类需按专家组共识进行筛查、监测、风险评估和风险减轻

指南或共识出处

  • Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline(Am J Psychiatry)

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Limited data are available to inform clinicians on how to manage concurrent substance use in the context of repetitive transcranial magnetic stimulation (rTMS) for the treatment of depressive, obsessive-compulsive, psychotic, or trauma-related disorders. The authors convened an international panel of 24 rTMS experts, representative of different geographic regions and subspecialities, and created a consensus guideline for clinicians and researchers on approaches to concurrent substance use in patients receiving rTMS as treatment for primary psychiatric disorders.

METHODS: A Delphi method survey and expert opinion elicited over consecutive rounds of surveys were used, with feedback and discussion after each round. Recommendation statements were established upon very high (≥80%) agreement.

RESULTS: Three rounds of surveys and feedback were sufficient to reach a consensus for most topics; where consensus could not be reached, the panel discussed limitations in the current evidence base. Informed by a synthesis of the literature and practice-based evidence, the expert panel provides several consensus recommendations on the topics of screening, monitoring, risk assessment, and mitigation associated with various degrees of substance use, and specific considerations for alcohol, cannabis, stimulants, and opioids. Instead of excluding all people who use substances, a nuanced approach should be taken based on an assessment of risk factors for clinical instability and severity of use. The most important safety risk with substance use is the presence of intoxication or withdrawal states, with the most data supporting seizure risk in unstable alcohol or nonmedical stimulant use. Although there is no evidence of reduced rTMS efficacy for a psychiatric disorder in the presence of concurrent substance use, the lack of data in this area warrants caution.

CONCLUSIONS: These recommendations can be readily implemented clinically and provide a framework for future research. In patients receiving rTMS for a primary psychiatric disorder, assessment and management of co-occurring substance use is complex, requiring greater attention, standardization, and further study.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

参考来源

  1. Tang VM, Aaronson S, Abdelghani M, et al. Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline. Am J Psychiatry. 2025. PMID: 40103354. doi:10.1176/appi.ajp.20240403

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。